Wayne Embree - Profile and Investment Details

Investor Profile

Wayne Embree is a Venture Capital, Corporate Venture Capital, Private Equity Firm based in Columbus, Ohio, United States with a diverse investment portfolio that includes companies such as Myonexus Therapeutics, MavenView, MentorcliQ, nChannel, F13 Works, Lyst Therapeutics, Scioto Biosciences, ProteoSense, Lentechs, Deep Lens, Supply Dynamics, Milo Biotechnology, iReconCars, sight4all, SafeWhite, Motivational Medicine, Creatively Alive, Seamless.AI, Upshift, Invirsa, Print Syndicate, Theravasc, Complion, Med-Compliance IQ, BeeHex, LLC, QuTel, Healthy Roster, EmployStream, Virtual Education Systems, Cube4, AwareAbility Technolgies, SHARE Mobility, NeuVanta, Cape Analytics, Clarivoy, MassMatrix, ALC Innovations, Basking Biosciences, Prevacept Infection Control, PopCom, Teraki, ZeoVation, PriorAuthNow, Updox, EndoSphere, Prevedere, smallTalk, inmobly, Celenex, Qahead, ORIS Intelligence, T-PRO Solutions, Innovate IP, Agile Ultrasonics Corporation, pH Matter, Aware, Simple-Fill, Matterport, Nexosis, Intellirod SpineScriptDrop, Ecolibrium Solar, SafeChain, 3Bar Biologics, Kare Intellex, Inc., Noxsano, Peerro, Ambassador Software Works, Unific, The Toasted Oat, . Over time, Wayne Embree has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Wayne Embree is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Autonomous Vehicles, Cybersecurity, Wellness, Enterprise Software, HR Tech, Apps, Task Management, Education, Artificial Intelligence (AI), Robotics, Information Technology (IT), Marketplace, Business Development, 3D Technology, Mobile, Software, Manufacturing, Biotechnology, Productivity Software, Legal Tech, Food and Beverage, Employee Benefits, Consumer Internet, Reviews and Recommendations, Consulting, Children, SaaS, Big Data, B2B, Therapeutics, Advanced Materials, Media and Entertainment, Pharmaceuticals, Service Industry, Risk Management, Business Intelligence may find it worthwhile to explore potential connections with Wayne Embree, as their portfolio suggests a familiarity and interest in this area.

Understanding Wayne Embree’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.